跳至主要内容
临床试验/EUCTR2015-002882-41-AT
EUCTR2015-002882-41-AT进行中(未招募)不适用

Sono-­Response-­StudyA Pilot Study on the use of contrast enhanced ultrasound in Crohn’s disease

Medical University of Vienna (MUW)0 个研究点开始时间: 2015年11月5日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) Men and women above the age of 18 with an established diagnosis of Crohn’s disease for at least 3
  • months (according to a histology from an ileocolonoscopy evidentiary
  • for Crohn’s disease)
  • 2) Able and willing to provide written informed consent
  • 3) Crohn’s disease with evidence
  • of ileal or ileocolonic disease
  • 4) Clinically active disease as evidenced by a Harvey Bradshaw index of 8 or above
  • 5) Planned step-­-up in immunosuppressive therapy with an antiTNFalpha agent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 22
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 3

排除标准

  • 1) Ulcerative colitis or indeterminate colitis
  • 2) Isolated colonic Crohn’s disease
  • 3) Contraindications for undergoing magnetic resonance imaging with computed tomography or other methods planned to be applied for disease/response assessment as substitute for MRI
  • 4) Contraindications to undergo contrast enhanced ultrasound examinations
  • 5) Contraindications against therapy with an antiTNFalpha agent
  • 6) Inability to adhere to follow up schedule and/or provide information necessary to assess response parameters
  • 7) Unwilling or unable to undergo blood sampling
  • 8) Female subjects pregnant or planning pregnancy within the timeframe of the study participation
  • 9) Significant coronary heart disease, right-to-­left, bidirectional, or transient right-­to-­left cardiac shunt

研究者

发起方
Medical University of Vienna (MUW)

相似试验